Ceftazidime is a broad-spectrum cephalosporin antibiotic used to treat various bacterial infections [1]. It is effective against many Gram-positive and Gram-negative bacteria [1].
What kinds of infections does ceftazidime treat?
Ceftazidime is prescribed for serious infections, including:
* Respiratory tract infections: Such as pneumonia and bronchitis, particularly in patients with cystic fibrosis [1][2].
* Urinary tract infections: Complicated and uncomplicated cases [1].
* Skin and soft tissue infections: Including cellulitis and infected wounds [1].
* Intra-abdominal infections: Often in combination with other antibiotics [1].
* Bone and joint infections [1].
* Septicemia (bloodstream infection) [1].
* Meningitis [1].
It is also used for prophylaxis in certain surgical procedures [1].
How does ceftazidime work?
Ceftazidime functions by inhibiting bacterial cell wall synthesis [1]. It binds to penicillin-binding proteins (PBPs) located in the bacterial cell wall, preventing the cross-linking of peptidoglycan. This weakens the cell wall, leading to bacterial lysis and death [1].
Who makes ceftazidime and is it available generically?
Ceftazidime is available in generic forms [3]. Brands that have marketed ceftazidime include Fortaz [4].
When does the patent for ceftazidime expire?
Information regarding specific patent expiry dates for ceftazidime is available through resources like DrugPatentWatch.com [5].
What are the potential side effects of ceftazidime?
Common side effects may include diarrhea, nausea, vomiting, rash, and phlebitis at the injection site [1]. More serious side effects can include allergic reactions, changes in blood counts, and Clostridioides difficile-associated diarrhea [1].
How is ceftazidime administered?
Ceftazidime is typically administered intravenously (IV) or intramuscularly (IM) [1]. The dosage and duration of treatment depend on the type and severity of the infection, as well as the patient's kidney function [1].
What are the risks of using ceftazidime?
Risks associated with ceftazidime use include the development of antibiotic resistance if not used appropriately [1]. Patients with a history of hypersensitivity to cephalosporins or penicillin may experience allergic reactions [1].
Are there alternatives to ceftazidime?
Alternatives to ceftazidime depend on the specific infection and the susceptibility of the bacteria. Other cephalosporins, carbapenems, fluoroquinolones, or combination antibiotic therapies may be used [6].
How does ceftazidime compare to other antibiotics?
Ceftazidime is a third-generation cephalosporin with a broad spectrum of activity. Its specific advantages include its potent activity against Pseudomonas aeruginosa [1]. Other cephalosporins, such as cefepime (a fourth-generation cephalosporin), offer an even broader spectrum, including enhanced activity against some Gram-positive bacteria and some Gram-negative bacteria resistant to third-generation agents [7].
Can ceftazidime be used in combination therapy?
Yes, ceftazidime is often used in combination with other antibiotics, such as metronidazole, for the treatment of polymicrobial infections, including intra-abdominal infections [1][6]. This approach broadens the antimicrobial coverage and can help overcome resistance mechanisms.
What is the clinical evidence supporting ceftazidime use?
Numerous clinical trials have established the efficacy and safety of ceftazidime for various bacterial infections [8]. Studies have demonstrated its effectiveness in treating hospital-acquired pneumonia, complicated urinary tract infections, and infections caused by susceptible Gram-negative organisms [8].
Are there specific patient populations for whom ceftazidime is particularly important?
Ceftazidime is a cornerstone in managing serious infections in patients with compromised immune systems and in those with cystic fibrosis, where Pseudomonas aeruginosa infections are common and difficult to treat [2][8].
Sources:
[1] https://www.ncbi.nlm.nih.gov/books/NBK470394/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866060/
[3] https://www.goodrx.com/ceftazidime
[4] https://www.drugs.com/drug-master/fortaz-1924
[5] https://drugpatentwatch.com/
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357538/
[7] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007676/
[8] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842609/